Mobile Application for IBD Patients With Biologics

Rijnstate Hospital

Status: Completed

Conditions: Inflammatory Bowel Diseases

Treatments: Device: Personalised mobile application for IBD patients

Study type: Interventional

Funder types: Other

Identifiers

NCT04254614

NL72353.091.19

Details and patient eligibility

About

Monitoring of biologic treatment in patients with inflammatory bowel disease (IBD) is important given the increased risk of infections. In this study we aim to evaluate the use of a mobile application to guide IBD patients and facilitate the monitoring of biologic treatment.

Full description

Biologic treatment can induce and maintain remission in patients with inflammatory bowel disease (IBD). However, biologics are associated with increased risk of infections. Therefore, it is important to regularly monitor patients during the course of therapy. This process can be time consuming for patients as well as clinicians. Mobile applications, have the potential to guide patients and facilitate monitoring of biologic treatment. In this study we aim to evaluate the use of a mobile application to guide IBD patients during biologic treatment. Adult patients with diagnosis of IBD treated with biologics will be included. The mobile application with personalised content will give patients information about their treatment, reminders for example when blood tests and questionnaires to check for adverse events.

Enrollment: 55 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of inflammatory bowel disease
• Treatment with infliximab or vedolizumab
• Ability to read and understand Dutch language

Exclusion criteria

• Patients recently started with biologic treatment

Trial design

Primary purpose: Health Services Research

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

55 participants in 1 patient group

Personalised mobile application for IBD patients

Experimental group

Description:

This is a cohort study with a 1 arm intervention group, without a control group. Patients included in this study will be invited to use a mobile application. The content and functionalities of this application are described in the intervention section.

Treatment:

Device: Personalised mobile application for IBD patients